Check out Behnam's recent publications:
Introducing our library of pre-developed assays for cell and gene therapies
In a presentation taking place in the opening plenary session of the Gene Therapy Analytical Development EU summit 2021, Dr Behnam Ahmadian, Global Head of Process Development for the Cell & Gene Technologies Business Unit at Lonza, introduces a ...
Allogeneic CAR-T manufacturing webinar
Webinar titled 'Focus on allogeneic CAR-Ts manufacturing challenges and solutions' hosted by Bioinsights and featuring three lonza speakers from commercial development, Research & Development and Process Development.
Phacilitate Special Interest Group on Automation paper
40 page report co-authored from multiple key players in the industry on automation in cell and gene therapy.
Report of the international conference on manufacturing
Elsevier peer-reviewed paper and international conference report on manufacturing and testing of pluripotent stem cells.
Bioprocessing of cGMP Human Induced Pluripotent Stem Cells
Poster presented at ISCT 2018 on cGMP bioprocessing of hiPSCs in suspension bioreactors
Human-Induced Pluripotent Stem Cells Manufactured
Frontiers in Medicine peer-reviewed paper on hIPSCs cGMP manufacturing.
Spotlight on Product Characterization
Bioinsights sponsored inteview on analytical tools, assay development and characterization.
A Newly Defined and Xeno-Free Culture Medium Supports
PLOS one Peer reviewed paper on medium replacement in the generation of hiPSCs.
Detailed Characterization of Human Induced Pluripotent
Springerlink.com peer reviewed paper on the characterization of iPSCs manufacturing.
Manufacturing Human Induced-Pluripotent Stem Cells
BPI cell therapy Peer-reviewed case study on manufacturing hiPSCs for clinical application.